Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia
Melissa R. Lyman, … , Won Jin Ho, Neeha Zaidi
Melissa R. Lyman, … , Won Jin Ho, Neeha Zaidi
Published June 26, 2025
Citation Information: JCI Insight. 2025;10(15):e191595. https://doi.org/10.1172/jci.insight.191595.
View: Text | PDF
Research Article Immunology Inflammation Oncology

Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia

  • Text
  • PDF
Abstract

Pancreatic ductal adenocarcinoma (PDAC) has a poor survival rate due to late detection. PDAC arises from precursor microscopic lesions, termed pancreatic intraepithelial neoplasia (PanIN), that develop at least a decade before overt disease; this provides an opportunity to intercept PanIN-to-PDAC progression. However, immune interception strategies require full understanding of PanIN and PDAC cellular architecture. Surgical specimens containing PanIN and PDAC lesions from a unique cohort of 5 treatment-naive patients with PDAC were surveyed using spatial omics (proteomic and transcriptomic). Findings were corroborated by spatial proteomics of PanIN and PDAC from tamoxifen-inducible KPC mice. We uncovered the organization of lymphoid cells into tertiary lymphoid structures (TLSs) adjacent to PanIN lesions. These TLSs lacked CD21+CD23+ B cells compared with more mature TLSs near the PDAC border. PanINs harbored mostly CD4+ T cells, with fewer Tregs and exhausted T cells than PDAC. Peritumoral space was enriched with naive CD4+ and central memory T cells. These observations highlight the opportunity to modulate the immune microenvironment in PanINs before immune exclusion and immunosuppression emerge during progression into PDAC.

Authors

Melissa R. Lyman, Jacob T. Mitchell, Sidharth Raghavan, Luciane T. Kagohara, Amanda L. Huff, Saurav D. Haldar, Sarah M. Shin, Samantha Guinn, Benjamin Barrett, Gabriella Longway, Alexei Hernandez, Erin M. Coyne, Xuan Yuan, Lalitya Andaloori, Jiaying Lai, Yun Zhou Liu, Rachel Karchin, Anuj Gupta, Ashley L. Kiemen, André Forjaz, Denis Wirtz, Pei-Hsun Wu, Atul Deshpande, Jae W. Lee, Todd D. Armstrong, Nilofer S. Azad, Jacquelyn W. Zimmerman, Laura D. Wood, Robert A. Anders, Elizabeth D. Thompson, Elizabeth M. Jaffee, Elana J. Fertig, Won Jin Ho, Neeha Zaidi

×

Figure 1

Immune-rich regions were identified and segmented for IMC analysis.

Options: View larger image (or click on image) Download as PowerPoint
Immune-rich regions were identified and segmented for IMC analysis.
(A) ...
(A) Visualization of the 4 different regions (normal, low-grade PanIN, PDAC, chronic pancreatitis) annotated by an expert pathologist. (B) Bar plots of the number of unique and shared mutations between PanIN lesions and PDAC from patients 1, 2, and 5. (C) Heatmap showing the relative expression of each marker in the IMC panel used to identify each cell type. (D) Total number of cells analyzed by region (left) with visualization of the percentage distribution of cells per region (right) (total area of tissue and number of samples used in the subsequent analysis is summarized in Supplemental Table 2).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts